Generic version of a drug already on the market, which can suppress and prevent HIV, would still yield 30% profit if the current price was slashed, researchers say

Lenacapavir , sold as Sunlenca by US pharmaceutical giant Gilead, currently costs $42,250 for the first year. The company is being urged to make it available at a thousand times less than that price worldwide.

UNAids said it could “herald a breakthrough for HIV prevention” if the drug was available “rapidly and affordably”.

Given by injection every six months, lenacapavir can prevent infection and suppress HIV in people who are already infected.

In a trial, the drug offered 100% protection to more than 5,000 women in South Africa and Uganda, according to results announced by Gilead last month.

  •  MonkeyTown   ( @MonkeyTown@beehaw.org ) 
    6•1 month ago

    Considering how much of their research and development costs are funded by grants from governments, I’d say just get rid of private pharmaceutical companies entirely if they can’t play nice.

    Give them a choice. No drug revenue at all, or any paradigm-changing drugs get their license bought out cheap.

    They either go out of business entirely, and governments and academic institutions take over the work (so so much of it is paid with grants anyway, I don’t think pharma companies should keep any profits unless they fund 100% of the r&d for it, which they won’t), or they agree to sell the patents that can literally change the trajectory of a society for a fair “this is the actual amount of work we put into it plus 200% to make it worth doing.”

    If they can’t be happy with that, the default option is they get to do nothing so…

    But again, the profit motive of big pharma leads us to places like the opioid crisis, side effects that aren’t disclosed or even fully studied, etc. and I don’t think we should be trusting drug development to for-profit companies, at least not without much much better protections for patients and much more stringent requirements on proof of efficacy and safety.

    •  coyotino [he/him]   ( @theangriestbird@beehaw.org ) English
      8•1 month ago

      so much of it is paid with grants anyway, I don’t think pharma companies should keep any profits unless they fund 100% of the r&d for it, which they won’t

      This is a strong point. If so much of this R&D is government-funded, then why tf are the drug companies allowed to profit from it? Corporate welfare is America’s only real welfare problem.